Literature DB >> 22238265

Estimating abundances of retroviral insertion sites from DNA fragment length data.

Charles C Berry1, Nicolas A Gillet, Anat Melamed, Niall Gormley, Charles R M Bangham, Frederic D Bushman.   

Abstract

MOTIVATION: The relative abundance of retroviral insertions in a host genome is important in understanding the persistence and pathogenesis of both natural retroviral infections and retroviral gene therapy vectors. It could be estimated from a sample of cells if only the host genomic sites of retroviral insertions could be directly counted. When host genomic DNA is randomly broken via sonication and then amplified, amplicons of varying lengths are produced. The number of unique lengths of amplicons of an insertion site tends to increase according to its abundance, providing a basis for estimating relative abundance. However, as abundance increases amplicons of the same length arise by chance leading to a non-linear relation between the number of unique lengths and relative abundance. The difficulty in calibrating this relation is compounded by sample-specific variations in the relative frequencies of clones of each length.
RESULTS: A likelihood function is proposed for the discrete lengths observed in each of a collection of insertion sites and is maximized with a hybrid expectation-maximization algorithm. Patient data illustrate the method and simulations show that relative abundance can be estimated with little bias, but that variation in highly abundant sites can be large. In replicated patient samples, variation exceeds what the model implies-requiring adjustment as in Efron (2004) or using jackknife standard errors. Consequently, it is advantageous to collect replicate samples to strengthen inferences about relative abundance.

Entities:  

Mesh:

Year:  2012        PMID: 22238265      PMCID: PMC3307109          DOI: 10.1093/bioinformatics/bts004

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  20 in total

1.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Christof von Kalle; Manfred Schmidt; Françoise Le Deist; Nicolas Wulffraat; Elisabeth McIntyre; Isabelle Radford; Jean-Luc Villeval; Christopher C Fraser; Marina Cavazzana-Calvo; Alain Fischer
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

2.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

3.  Estimating the population size for capture-recapture data with unequal catchability.

Authors:  A Chao
Journal:  Biometrics       Date:  1987-12       Impact factor: 2.571

4.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

5.  The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.

Authors:  Nicolas A Gillet; Nirav Malani; Anat Melamed; Niall Gormley; Richard Carter; David Bentley; Charles Berry; Frederic D Bushman; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

6.  Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates.

Authors:  Manfred Schmidt; Denise A Carbonaro; Carsten Speckmann; Manuela Wissler; John Bohnsack; Melissa Elder; Bruce J Aronow; Jan A Nolta; Donald B Kohn; Christof von Kalle
Journal:  Nat Med       Date:  2003-03-17       Impact factor: 53.440

7.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

8.  Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries.

Authors:  Daniel Aird; Michael G Ross; Wei-Sheng Chen; Maxwell Danielsson; Timothy Fennell; Carsten Russ; David B Jaffe; Chad Nusbaum; Andreas Gnirke
Journal:  Genome Biol       Date:  2011-02-21       Impact factor: 13.583

9.  A method to sequence and quantify DNA integration for monitoring outcome in gene therapy.

Authors:  Troy Brady; Shoshannah L Roth; Nirav Malani; Gary P Wang; Charles C Berry; Philippe Leboulch; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo; Eirini P Papapetrou; Michel Sadelain; Harri Savilahti; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2011-03-16       Impact factor: 16.971

10.  Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.

Authors:  Rick S Mitchell; Brett F Beitzel; Astrid R W Schroder; Paul Shinn; Huaming Chen; Charles C Berry; Joseph R Ecker; Frederic D Bushman
Journal:  PLoS Biol       Date:  2004-08-17       Impact factor: 8.029

View more
  65 in total

1.  Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants.

Authors:  Samson J Koelle; Diego A Espinoza; Chuanfeng Wu; Jason Xu; Rong Lu; Brian Li; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

2.  Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.

Authors:  Jennifer E Adair; Brian C Beard; Grant D Trobridge; Tobias Neff; Jason K Rockhill; Daniel L Silbergeld; Maciej M Mrugala; Hans-Peter Kiem
Journal:  Sci Transl Med       Date:  2012-05-09       Impact factor: 17.956

Review 3.  Integration site selection by retroviruses and transposable elements in eukaryotes.

Authors:  Tania Sultana; Alessia Zamborlini; Gael Cristofari; Pascale Lesage
Journal:  Nat Rev Genet       Date:  2017-03-13       Impact factor: 53.242

4.  Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Authors:  Rebecca T Veenhuis; Abena K Kwaa; Caroline C Garliss; Rachel Latanich; Maria Salgado; Christopher W Pohlmeyer; Christopher L Nobles; John Gregg; Eileen P Scully; Justin R Bailey; Frederic D Bushman; Joel N Blankson
Journal:  JCI Insight       Date:  2018-09-20

5.  HIV-1 integration landscape during latent and active infection.

Authors:  Lillian B Cohn; Israel T Silva; Thiago Y Oliveira; Rafael A Rosales; Erica H Parrish; Gerald H Learn; Beatrice H Hahn; Julie L Czartoski; M Juliana McElrath; Clara Lehmann; Florian Klein; Marina Caskey; Bruce D Walker; Janet D Siliciano; Robert F Siliciano; Mila Jankovic; Michel C Nussenzweig
Journal:  Cell       Date:  2015-01-29       Impact factor: 41.582

6.  Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples.

Authors:  Martijn H Brugman; Julia D Suerth; Michael Rothe; Sebastian Suerbaum; Axel Schambach; Ute Modlich; Olga Kustikova; Christopher Baum
Journal:  Hum Gene Ther Methods       Date:  2013-03-14       Impact factor: 2.396

7.  Vector integration and tumorigenesis.

Authors:  Christof von Kalle; Annette Deichmann; Manfred Schmidt
Journal:  Hum Gene Ther       Date:  2014-06       Impact factor: 5.695

8.  Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites.

Authors:  Erik Serrao; Peter Cherepanov; Alan N Engelman
Journal:  J Vis Exp       Date:  2016-03-22       Impact factor: 1.355

9.  CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration.

Authors:  Christopher L Nobles; Scott Sherrill-Mix; John K Everett; Shantan Reddy; Joseph A Fraietta; David L Porter; Noelle Frey; Saar I Gill; Stephan A Grupp; Shannon L Maude; Donald L Siegel; Bruce L Levine; Carl H June; Simon F Lacey; J Joseph Melenhorst; Frederic D Bushman
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

10.  HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Authors:  F Maldarelli; X Wu; L Su; F R Simonetti; W Shao; S Hill; J Spindler; A L Ferris; J W Mellors; M F Kearney; J M Coffin; S H Hughes
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.